Efficacy and safety of gemcitabine-capecitabine combination therapy for pancreatic cancer: A systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Recent randomized controlled trials revealed the combination of gemcitabine and capecitabine (GemCap) regime shows promising efficacy in pancreatic cancer patients. Here, we conducted a meta-analysis to compare the efficacy and safety of gemcitabine (Gem) with GemCap for pancreatic cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouyang, Guoqing, Wu, Yongrong, Liu, Zhen, Lu, Wuchang, Li, Shuai, Hao, Shuqing, Pan, Guangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191365/
https://www.ncbi.nlm.nih.gov/pubmed/35049189
http://dx.doi.org/10.1097/MD.0000000000027870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191365/
https://www.ncbi.nlm.nih.gov/pubmed/35049189
http://dx.doi.org/10.1097/MD.0000000000027870

Ejemplares similares